Sanders-Brown Center on Aging

UK researchers explore the relationship between Down syndrome and Alzheimer's disease

Mar 20, 2024, 7:24 AM

Thanks to medical advances, people with Down syndrome are living longer and fuller lives; however there is still much to learn about the Down syndrome brain.

Chemicals in plastics could be a risk factor for Alzheimer’s

Feb 28, 2024, 7:18 AM

Researchers at the University of Kentucky are studying how elements of our natural surroundings can be potential risk factors for Alzheimer’s disease — including chemicals widely used in plastics.

13th Markesbery Symposium Community Session

Nov 18, 2023, 8:00 AM – 12:00 PM

Join us for the 13th Annual Markesbery Symposium Community Session! Researchers will share the latest research updates regarding degenerative brain disease. Along with Sanders-Brown researchers, guest researchers include Dr. Malu Tansey and Dr. David Morgan. The event is free. Continental breakfast begins at 8 am with presentations following at 9 am. Bring your questions for the expert panel.

Markesbery Symposium on Aging and Dementia Scientific Session

Nov 17, 2023, 11:00 AM – 4:30 PM

Join the UK Sanders-Brown Center on Aging for the 13th Annual Markesbery Symposium on Aging and Dementia. Researchers will come together to share current research findings and the latest updates on dementia, particularly as related to Alzheimer's disease and healthy brain aging. The event is free and open to the public; however, you must register to attend.

UK researchers 1st to show multiple sclerosis drug can be used as Alzheimer’s therapy

Sep 1, 2023, 6:58 AM

A team of researchers at the University of Kentucky has found that a drug used to treat multiple sclerosis (MS) is potentially effective as a therapy for Alzheimer’s disease.

Sanders-Brown Center on Aging featured in special on WKYT this Monday

Aug 31, 2023, 6:48 AM

Labor Day, September 4, WKYT-TV, is highlighting the world-class work going on at the University of Kentucky’s Sanders-Brown Center on Aging. The Lexington-based CBS affiliate will air a 30-minute special on their second station, The CW, at 6:30 p.m.

New study shows anti-inflammatory drugs as a promising target for Alzheimer’s disease

Jul 17, 2023, 7:03 AM

A recent study from the lab of the Sanders-Brown Center on Aging Director Linda Van Eldik, Ph.D., centers around the idea that various anti-inflammatory drugs could be effective treatments for Alzheimer’s disease.

Drug studied at UK is 1st disease-modifying therapy in U.S. approved to treat Alzheimer’s

Jul 12, 2023, 7:07 AM

The U.S. Food and Drug Administration (FDA) granted full approval to lecanemab, marketed as Leqembi, for the treatment of Alzheimer’s disease. The University of Kentucky’s Sanders-Brown Center on Aging has been working with this drug and others like it for more than a decade.

Getty%20Images%20dementia%20patient%20MRI%20close%20up.jpg

UK social work researcher to study effects of PTSD on dementia

Jun 21, 2023, 7:20 AM

Karen Lawrence, Ph.D., M.S.W., will work to better understand the connection between PTSD and dementia by analyzing data from 42 Alzheimer’s Disease Research Centers across the U.S.

UK researchers receive funding to study how genetic factors contribute to dementia

Jun 16, 2023, 7:21 AM

A Sanders-Brown Center on Aging project will focus on how genetic factors contribute to dementia. The work was recently awarded funding from the National Institute on Aging that will total more than $1.7 million.

Subscribe to Sanders-Brown Center on Aging